Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Minoo Javanmardian, PhD

Partner, Health and Life Sciences, Oliver Wyman

Researchers Explore Organ Recovery and Transplantation Opportunities

Although nearly half of US adults are registered organ donors, transplant waitlists remain long. New research outlines how to accelerate improvement and offers key considerations for payers and regulators.

Partner and CMO, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Global Head, Provider, Health and Life Sciences, Oliver Wyman

Future Truths: Inevitable and Inspiring

The current supply of inpatient beds is far higher than what we need now, or even what we'll need a decade from now.

Partner, Health and Life Sciences, Oliver Wyman
Engagement Manager, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Oliver Wyman Actuarial Consulting

The current supply of inpatient beds is far higher than what we need now, or even what we'll need a decade from now.

Partner, Health and Life Sciences, Oliver Wyman
Engagement Manager, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Oliver Wyman Actuarial Consulting

Part 4: State-by-State Market Impact

Six factors that dictate the kind of health coverage people who've lost their jobs want next.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Oliver Wyman Actuarial Consulting
Senior Consultant, Oliver Wyman

Health systems have seen a breakthrough in agility. Analyzing earlier experiences will drive its sustainability.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Organizational Effectiveness, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Market dynamics are ripe for M&A activity. But before being enticed by a mirage, leaders must revisit old lessons.

Principal, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

The coronavirus is transforming the status quo of cost, sustainability, and affordability.

Partner, Health and Life Sciences, Oliver Wyman
Global Head, Provider, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

The aviation and finance industries' past experiences accessing federal programs mirror providers' current experiences.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

A working COVID-19 checklist of solutions to follow along each step of the patient pathway.

Partner, Health and Life Sciences, Oliver Wyman
Global Head, Provider, Health and Life Sciences, Oliver Wyman

For coronavirus patients, and all patients, being without a bed means being without a place to go.

Partner, Health and Life Sciences, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe